Publication Name	World Journal of Cardiology
Manuscript ID	9452
Country	United States

Received	2014-02-13 08:23
Peer-Review Started	2014-02-13 09:49
To Make the First Decision	2014-03-12 16:40
Return for Revision	2014-03-20 20:45
Revised	2014-03-25 04:41
Second Decision	2014-05-29 08:55
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-05-29 09:44
Articles in Press	2014-05-29 11:56
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-08-28 14:04
Publish the Manuscript Online	2014-09-17 14:32

ISSN	1949-8462 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Cardiac & Cardiovascular Systems
Manuscript Type	Topic Highlights
Article Title	Hypertrophic cardiomyopathy: Can the noninvasive diagnostic testing identify high risk patients?
Manuscript Source	Invited Manuscript
All Author List	Li Zhang, Obinna Mmagu, Liwen Liu, Dayuan Li, Yuxin Fan, Adrian Baranchuk and Peter R Kowey
Funding Agency and Grant Number	Funding Agency Grant Number W.W. Smith Charitable Trust
Corresponding Author	Li Zhang, MD, Associate Professor, Center for Clinical Cardiology, Lankenau Institute for Medical Research, Lankenau Medical Center, Jefferson Medical College, R129A, 100 Lancaster Avenue, Wynnewood, PA 19008, United States. ldlzhang@gmail.com
Key Words	Hypertrophic cardiomyopathy; Sudden cardiac death; Noninvasive diagnostic testing
Core Tip	Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death (SCD) in the young, particularly among athletes. Noninvasive diagnostic testing is important for risk assessment. Extreme left ventricular hypertrophy, documented ventricular tachycardia and fibrillation increase the risk of SCD. Fragmented QRS complex and T wave inversion in multiple leads are more common in high risk patients. Cardiac magnetic resonance imaging with late gadolinium enhancement, patchy myocardial fibrosis within the area of hypertrophy can be detected, which is also helpful in risk stratification. Genetic testing is encouraged in all cases, especially in those with family history of HCM and SCD.
Publish Date	2014-09-17 14:32
Citation	Zhang L, Mmagu O, Liu L, Li D, Fan Y, Baranchuk A, Kowey PR. Hypertrophic cardiomyopathy: Can the noninvasive diagnostic testing identify high risk patients? World J Cardiol 2014; 6(8): 764-770
URL	http://www.wjgnet.com/1949-8462/full/v6/i8/764.htm
DOI	http://dx.doi.org/10.4330/wjc.v6.i8.764

Full Article (PDF)	WJC-6-764.pdf
Full Article (Word)	WJC-6-764.doc
Manuscript File	9452-Review.doc
Answering Reviewers	9452-Answering reviewers.pdf
Copyright License Agreement	9452-Copyright assignment.pdf
Peer-review Report	9452-Peer review(s).pdf
Scientific Misconduct Check	9452-CrossCheck.jpg
Scientific Editor Work List	9452-Scientific editor work list.pdf